BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1888703)

  • 1. [Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcell-mediated chromosome transfer].
    Miyamoto S; Sasaki M; Nishida M; Wake N
    Hum Cell; 1991 Mar; 4(1):38-43. PubMed ID: 1888703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma.
    Matsuda T; Sasaki M; Kato H; Yamada H; Cohen M; Barrett JC; Oshimura M; Wake N
    Oncogene; 1997 Dec; 15(23):2773-81. PubMed ID: 9419968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome and cellular origin of choriocarcinoma.
    Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.
    Yamada H; Wake N; Fujimoto S; Barrett JC; Oshimura M
    Oncogene; 1990 Aug; 5(8):1141-7. PubMed ID: 2392323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant potential of homozygous and heterozygous complete moles.
    Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
    Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The propensity to malignancy of dispermic heterozygous moles.
    Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
    Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The propensity to malignancy of dispermic, heterozygous moles].
    Hashimoto M
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):564-72. PubMed ID: 2960601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The propensity to malignant changes in heterozygous moles].
    Seki T; Fujita H; Okubo H; Shiina Y; Wake N; Ichinoe K; Kuroda M; Satoh H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2221-8. PubMed ID: 7153599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understandings of the molecular genetics of gestational trophoblastic diseases.
    Li HW; Tsao SW; Cheung AN
    Placenta; 2002 Jan; 23(1):20-31. PubMed ID: 11869089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of hydatidiform moles].
    Brackertz M
    Geburtshilfe Frauenheilkd; 1983 Jul; 43(7):461-8. PubMed ID: 6555112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successive activation of the platelet-derived growth factor beta receptor and platelet-derived growth factor B genes correlates with the genesis of human choriocarcinoma.
    Holmgren L; Flam F; Larsson E; Ohlsson R
    Cancer Res; 1993 Jun; 53(12):2927-31. PubMed ID: 8504434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation of imprinting in trophoblastic disease.
    Ariel I; Lustig O; Oyer CE; Elkin M; Gonik B; Rachmilewitz J; Biran H; Goshen R; de Groot N; Hochberg A
    Gynecol Oncol; 1994 May; 53(2):212-9. PubMed ID: 8188082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of gestational trophoblastic neoplasia: a review.
    Fulop V; Mok SC; Berkowitz RS
    J Reprod Med; 2004 Jun; 49(6):415-22. PubMed ID: 15283047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of c-onc genes in choriocarcinoma cells].
    Fujino T
    Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.